Erythropoiesis stimulating agents and nephroprotection: is there any room for new trials? - Wikidata - awgldk - TriplyDB

Erythropoiesis stimulating agents and nephroprotection: is there any room for new trials?

Erythropoiesis stimulating agents and nephroprotection: is there any room for new trials?

http://www.wikidata.org/entity/Q53513618

about

Erythropoiesis stimulating agents and nephroprotection: is there any room for new trials?

http://www.wikidata.org/entity/Q53513618

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Erythropoiesis stimulating agents and nephroprotection: is there any room for new trials?

@en

Erythropoiesis stimulating agents and nephroprotection: is there any room for new trials?

@nl

type

label

Erythropoiesis stimulating agents and nephroprotection: is there any room for new trials?

@en

Erythropoiesis stimulating agents and nephroprotection: is there any room for new trials?

@nl

prefLabel

Erythropoiesis stimulating agents and nephroprotection: is there any room for new trials?

@en

Erythropoiesis stimulating agents and nephroprotection: is there any room for new trials?

@nl

P1433

Q53513618-C081BE1B-E84F-4AF8-B54E-0363220D9AE4

P1476

Q53513618-7C5B8985-0C78-4F55-B5E2-9B324C19E8BB

P2093

Q53513618-0A034CF3-56ED-4A2A-95C9-CE9574B03A26

Q53513618-7E50AD99-424F-4F80-8347-C33E3A64D13D

P2860

Q53513618-0026815F-94AE-4DF1-A9BF-3E837B06CDE6

Q53513618-007AC413-2956-4580-9D24-2A7EB8C43C74

Q53513618-02AB1965-3DF3-4720-8E68-29566F3A8934

Q53513618-1146FA74-9CE4-4BF9-BA9B-F10C021C4824

Q53513618-1816A2E5-E168-4374-9E8D-C5B88014AF18

Q53513618-1CEFBCB2-DC5A-4DAA-845A-305C786032DA

Q53513618-1E8722E9-3787-45F7-897B-890E5404BB37

Q53513618-2B7DFBDE-33CC-4CFC-9281-531C6555044A

Q53513618-30CE1884-0A6C-4FC8-BD9A-75B153CBFF0C

Q53513618-31EDDFE5-AA1C-4DB2-BF0E-20C7EC0D4974

P304

Q53513618-B7DA35CF-9976-4BBD-AA01-A3CC2E7C5929

P31

Q53513618-98686C5F-4F9F-40B2-B10F-8B36FA6CDE27

P356

Q53513618-3DC06D33-3277-487C-B580-3AF98249EAF6

P407

Q53513618-292E8BED-06FD-4049-A85B-88E5B304FD2F

P433

Q53513618-9678BE8F-8824-4FB3-BC90-6988FA086DDA

P478

Q53513618-22AC0B73-3A88-4EEA-BF9A-6AA482377E5B

P577

Q53513618-C15D3858-4850-4D40-8079-08749ADE1E30

P698

Q53513618-893FE8D6-ACB2-40AD-A291-A36679D327CD

P356

P1433

Nephrology Dialysis Transplantation

P1476

Erythropoiesis stimulating agents and nephroprotection: is there any room for new trials?

@en

P2093

Alessandro Zuccalà

http://www.w3.org/2001/XMLSchema#string

Lucia Del Vecchio

http://www.w3.org/2001/XMLSchema#string

P2860

Erythropoietin-mediated protection in kidney transplantation: nonerythropoietic EPO derivatives improve function without increasing risk of cardiovascular events

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

Multicentre prospective validation of a urinary peptidome-based classifier for the diagnosis of type 2 diabetic nephropathy.

Longitudinal progression trajectory of GFR among patients with CKD.

Diagnosis and Prediction of CKD Progression by Assessment of Urinary Peptides

Effect of hemoglobin target on progression of kidney disease: a secondary analysis of the CHOIR (Correction of Hemoglobin and Outcomes in Renal Insufficiency) trial.

Pleiotropic renal actions of erythropoietin.

Periostin: novel tissue and urinary biomarker of progressive renal injury induces a coordinated mesenchymal phenotype in tubular cells

Epoetin beta pegol alleviates oxidative stress and exacerbation of renal damage from iron deposition, thereby delaying CKD progression in progressive glomerulonephritis rats

P304

211-214

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NDT/GFW432

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P577

2017-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28186552

http://www.w3.org/2001/XMLSchema#string